Grant: Doctoral Research Award - PA: Biomedical/Clinical HIV/AIDS Research
Direct Payment
$70,000.00
Investigating the intrinsic resistance of human hematopoietic stem and progenitor cells to HIV-1 infection
FY 2010-11
Summary
Human immunodeficiency virus (HIV) causes disease by infecting multiple types of blood cells. Some of these target cells have ways of protecting themselves from infection, in the form of cellular anti-viral molecules and proteins. However, the virus has also evolved ways to counteract cellular protection and ensure its own survival, giving rise to a constant evolutionary battle between virus and host. Therefore, it is important to not only study the role of viral factors, but also that of host factors, in HIV-related diseases. Adult blood stem cells are cells that reside in the bone marrow and give rise to all types of circulating blood cells. These stem cells are interesting in that they are very resistant to HIV infection, but when low-level infection is established, they act as long-lived viral reservoirs, making it impossible to eradicate the infection with antiviral drugs. My research aims to identify protective factors naturally occurring in blood stem cells that make them resistant to HIV, with the prospect of up-regulating these factors to help fight HIV infections. On the other hand, HIV-based viral vectors are ideal delivery vehicles for gene therapy, but their use in blood stem cells has been hampered by the low efficiency of gene transfer. If anti-HIV factors in blood stem cells can be identified and down regulated, it would make these cells much more amenable to therapeutic gene delivery, for the treatment of blood-borne diseases ranging from congenital immunodeficiency to viral infections.
Department
Program
Doctoral Research Award - PA: Biomedical/Clinical HIV/AIDS Research
Recipient
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
219132
Name
Wang Xueqian
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating the intrinsic resistance of human hematopoietic stem and progenitor cells to HIV-1 infection
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Research Award - PA: Biomedical/Clinical HIV/AIDS Research
Keyworddelim
Hematopoietic Stem Cell; Intrinsic Immunity; Viral Pathogenesis
Abstract
Human immunodeficiency virus (HIV) causes disease by infecting multiple types of blood cells. Some of these target cells have ways of protecting themselves from infection, in the form of cellular anti-viral molecules and proteins. However, the virus has also evolved ways to counteract cellular protection and ensure its own survival, giving rise to a constant evolutionary battle between virus and host. Therefore, it is important to not only study the role of viral factors, but also that of host factors, in HIV-related diseases. Adult blood stem cells are cells that reside in the bone marrow and give rise to all types of circulating blood cells. These stem cells are interesting in that they are very resistant to HIV infection, but when low-level infection is established, they act as long-lived viral reservoirs, making it impossible to eradicate the infection with antiviral drugs. My research aims to identify protective factors naturally occurring in blood stem cells that make them resistant to HIV, with the prospect of up-regulating these factors to help fight HIV infections. On the other hand, HIV-based viral vectors are ideal delivery vehicles for gene therapy, but their use in blood stem cells has been hampered by the low efficiency of gene transfer. If anti-HIV factors in blood stem cells can be identified and down regulated, it would make these cells much more amenable to therapeutic gene delivery, for the treatment of blood-borne diseases ranging from congenital immunodeficiency to viral infections.
Competitiondate
201010
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Wang, Xueqian
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~